logo
Congress sends bill codifying $9B in DOGE cuts to Trump's desk

Congress sends bill codifying $9B in DOGE cuts to Trump's desk

The Hill18-07-2025
House Republicans late Thursday night approved the first batch of cuts made by the Department of Government Efficiency (DOGE), sending the $9 billion package to President Trump's desk in a big victory for the GOP.
The legislation — which claws back already-approved federal funding for foreign aid and public broadcasting — cleared the chamber in a mostly party-line 216-213 vote less than one day after the Senate passed the measure.
Trump is expected to sign the bill soon, as Republicans face a Friday deadline to enact the cuts or release the funds to the organizations they were appropriated for.
The package takes aim at the Corporation for Public Broadcasting, which funds NPR and PBS — two outlets that Republicans have labeled as biased — as well as the U.S. Agency for International Development (USAID), which DOGE targeted early in the Trump administration.
Republicans see the bill as a critical 'test run' for the party, as Trump administration officials have already indicated they aim to send multiple special requests to Congress to claw back more funding if the first package makes it through.
The request initially sent by the White House, known as a rescissions package, called for $9.4 billion in cuts to federal funding previously approved by Congress, including $8.3 billion for USAID and foreign aid, as well as more than $1 billion in public broadcasting funds.
But the White House ended up agreeing to exempt the President's Emergency Plan for AIDS Relief (PEPFAR), which was established under former President George W. Bush in 2003 and totaled about $400 million, after those cuts became a critical point of contention for moderate GOP lawmakers.
Republicans said they also reached a deal with the administration seeking to shield tribal stations from cuts to the Corporation For Public Broadcasting.
Republicans in both chambers have voiced strong support for the overall package and say the cuts are overdue. Many in the party have long scrutinized the scope of funding for foreign aid and accused public radio and television of political bias.
But the proposal also saw some resistance from Senate GOP appropriators earlier this week. The skeptics scolded the administration for trying to make an end run around the normal appropriations process and complained the request didn't have enough information, particularly when compared to the last rescissions request approved by Congress under former President George H. W. Bush.
Senate Appropriations Chair Susan Collins (R-Maine) specifically singled out a proposed $2.5 billion in cuts to the Development Assistance account. She noted in a statement that the account 'covers everything from basic education, to water and sanitation, to food security,' but said lawmakers still lacked key details as to how those programs would be affected.
White House budget chief Russell Vought told reporters on Thursday that the administration 'gave the same amount of detail and information that previous rescissions packages had.'
'This is the same level of detail that appropriators do when they provide a bill,' he argued. 'They say this is the amount that we're providing, or they have a rescission, and they put the amount of rescission, same thing that they do.'
He added that he respected people 'who are making the argument,' but he disagreed, noting the Office of Budget and Management worked with House appropriators while crafting the request.
Some Republicans have also warned the president's use of the rare tool to secure cuts to funding previously approved by Congress risks further eroding trust between both parties as lawmakers ramp up their annual funding work.
Vought said Thursday that another rescissions package is 'likely to come soon,' though he stopped short of offering specifics as to what programs could be on the chopping block.
Senate Democrats have warned the passage of this rescissions package and further efforts by the Trump administration to claw back funding with GOP-only votes threaten already fragile bipartisan negotiations to hash out full-year government funding bills.
Senate Minority Leader Chuck Schumer (D-N.Y.) earlier this month said passage of the rescissions package 'would be an affront to the bipartisan appropriations process.'
'That's why a number of Senate Republicans know it is absurd for them to expect Democrats to act as business as usual and engage in a bipartisan appropriations process to fund the government, while they concurrently plot to pass a purely partisan rescissions bill to defund those same programs negotiated on a bipartisan basis behind the scenes,' he continued, later adding: 'This is beyond a bait and switch – it is a bait and poison-to-kill.'
At the same time, Vought also told reporters Thursday that the annual appropriations process 'has to be less bipartisan.' He added that the power of the purse remains with Congress, but he continued: 'It's a ceiling. It is not a floor. It is not the notion that you have to spend every last dollar of that.'
Sen. Patty Murray (Wash.), top Democrat on the Senate Appropriations Committee, told The Hill shortly after his comments that Vought was 'absolutely wrong.'
'We have the power of the purse here, and we are not going to stand back and let the administration erode that.'
With less than 20 legislative days on the calendar ahead of a Sept. 30 government shutdown deadline, both chambers are running behind in marking up and pushing their annual funding bills across the floor — increasing the likelihood that Congress will have to resort to a stopgap measure to keep the lights on and buy time for lawmakers to finish their funding work.
But it remains an open question as to what that stopgap could look like.
Asked if House GOP leadership has begun discussing plans for a short-term funding patch, House Majority Leader Steve Scalise (R-La.) told The Hill on Wednesday: 'No, we haven't talked about that.'
'We want the appropriations process to work and ultimately to get an agreement in a negotiation with the Senate, as the Senate finally starts passing bills,' he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Susquehanna Lowers Wolfspeed (WOLF) PT to $1.50 Amid Q2 Semiconductor Preview
Susquehanna Lowers Wolfspeed (WOLF) PT to $1.50 Amid Q2 Semiconductor Preview

Yahoo

time8 minutes ago

  • Yahoo

Susquehanna Lowers Wolfspeed (WOLF) PT to $1.50 Amid Q2 Semiconductor Preview

Wolfspeed Inc. (NYSE:WOLF) is one of the tech stocks to buy according to analysts. On July 22, Susquehanna lowered the price target for Wolfspeed from $3 to $1.50, while maintaining a Neutral rating on the shares. The adjustment came as part of the firm's Q2 preview for the semiconductor group, with the firm expecting in-line to modest upside reports for the current quarter, driven by tariff-related demand pull-ins and sustained AI strength. However, Susquehanna's analysts did note increased uncertainty for the latter half of 2025 within the broader semiconductor market. In FQ3 2025, Wolfspeed showed a sequential revenue growth of 50% at its Mohawk Valley facility, which contributed $78 million in revenue. The company has also established a fully automated 200-millimeter manufacturing footprint for silicon carbide solutions and received ~$192 million in cash tax refunds from the Section 48D advanced manufacturing tax credit, which boosted liquidity. Close-up of Silicon Die are being Extracted from Semiconductor Wafer and Attached to Substrate by Pick and Place Machine. Computer Chip Manufacturing at Fab. Semiconductor Packaging Process. Additionally, Wolfspeed is actively engaging with customers for sampling 200-millimeter materials and pursuing new contracts for 200-millimeter wafer supply. But at the same time, the company is undergoing a restructuring, which includes a 30% reduction in its senior leadership team and projected restructuring charges of $400 million to $450 million for FY2025. Free cash flow during the quarter was also negative, at $168 million. Wolfspeed Inc. (NYSE:WOLF) is a semiconductor company that focuses on silicon carbide and gallium nitride/GaN technologies in Europe, Hong Kong, China, the rest of Asia-Pacific, the US, and internationally. While we acknowledge the potential of WOLF as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

MultiSensor AI Holdings Upgrades Asset Health Platform with MSAI Connect 2.0, Adds Enhanced AI, Seamless EAM Integration
MultiSensor AI Holdings Upgrades Asset Health Platform with MSAI Connect 2.0, Adds Enhanced AI, Seamless EAM Integration

Yahoo

time8 minutes ago

  • Yahoo

MultiSensor AI Holdings Upgrades Asset Health Platform with MSAI Connect 2.0, Adds Enhanced AI, Seamless EAM Integration

MultiSensor AI Holdings Inc. (NASDAQ:MSAI) is one of the tech stocks to buy according to analysts. On July 9, MultiSensor AI Holdings unveiled MSAI Connect 2.0. This upgrade to their asset health monitoring platform further reduces unplanned downtime, streamlines operations, and provides users with more actionable insights. MSAI Connect 2.0 introduces several key enhancements. Its AI functionality is supported by camera disturbance detection, which alerts operators to unintended sensor movements that might affect critical asset monitoring. Additionally, improved person and motion detection logic has been incorporated to reduce false-positive alerts. Photo by Vishnu Mohanan on Unsplash The platform integrates seamlessly with customers' existing Enterprise Asset Management/EAM systems. This creates a link between identifying issues and initiating corrective actions. MultiSensor AI Holdings Inc. (NASDAQ:MSAI) builds and deploys intelligent multi-sensing platforms with edge and cloud software solutions that use AI in the US and internationally. While we acknowledge the potential of MSAI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati

Citi Remains Bullish on Sana Biotechnology (SANA)
Citi Remains Bullish on Sana Biotechnology (SANA)

Yahoo

time18 minutes ago

  • Yahoo

Citi Remains Bullish on Sana Biotechnology (SANA)

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best biotech penny stocks to buy right now. Citi analyst Samantha Semenkow maintained a bullish stance on Sana Biotechnology, Inc. (NASDAQ:SANA), giving it a Buy rating on July 2 with a $15 price target. A scientist working with a microscope in a laboratory, focusing on a cell of a medical experiment. The analyst based the rating on Sana Biotechnology, Inc.'s (NASDAQ:SANA) potential in addressing notable market opportunities. Semenkow stated that the company's Type 1 Diabetes (T1D) program has exhibited considerable proof-of-concept results, with updated six-month data showing durable c-peptide production and successful graft survival without the need for immunosuppression. According to the analyst, this data consistency bolsters confidence in Sana Biotechnology, Inc.'s (NASDAQ:SANA) approach and paints a positive picture for its T1D asset, SC451, anticipated to make progress towards an IND as early as 2026. The same day, Morgan Stanley analyst Maxwell Skor also assumed coverage of Sana Biotechnology, Inc. (NASDAQ:SANA) with an Overweight rating and $12 price target. The analyst expects an investigational new drug filing as early as next year for its proprietary HIP-modified, islet stem-cell derived T1D therapy, SC451. Sana Biotechnology (NASDAQ:SANA) is a biotechnology company that specializes in using engineered cells as medicines. It develops cell engineering programs that transform treatment across several therapeutic areas with treatment gaps, including diabetes, oncology, the central nervous system, and B-cell-mediated autoimmune disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store